What are Myriad Genetics's profit margins?

Myriad Genetics (MYGN) runs a 70.0% gross margin and a -46.9% operating margin, with a -48.2% net margin.

Where do Myriad Genetics's ratios come from?

Every ratio is computed from Myriad Genetics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Myriad Genetics MYGN Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Profitability
Gross margin	69.9%0.0pp	69.9%+1.2pp	68.6%-1.6pp	70.2%—
Operating margin	-47%-32.2pp	-14.7%+19.4pp	-34.2%-13.4pp	-20.7%+6.9pp
Net margin	-44.4%-29.2pp	-15.2%+19.8pp	-35%-18.4pp	-16.5%-12.6pp
EBITDA margin	-40.4%-33.0pp	-7.4%+18.5pp	-26%-13.0pp	-13%+5.5pp
Returns
Return on equity	-68.5%-51.3pp	-17.2%+14.4pp	-31.6%-19.5pp	-12.1%-9.1pp
Return on assets	-42.2%-30.5pp	-11.7%+10.7pp	-22.5%-13.6pp	-8.9%-6.9pp
Return on invested capital	-67%-50.8pp	-16.2%+13.1pp	-29.3%-13.3pp	-15.9%+4.6pp
Efficiency
Asset turnover	1×+0.2×	0.8×+0.1×	0.6×+0.1×	0.5×0.0×
Inventory turnover	8.5×-1.7×	10.2×-1.0×	11.2×-0.2×	11.4×—
Liquidity
Current ratio	2.5×+0.7×	1.8×-0.2×	2×0.0×	2×-0.4×
Quick ratio	2.3×+0.6×	1.6×-0.2×	1.9×0.0×	1.9×-0.4×
Cash ratio	1.1×+0.4×	0.7×-0.2×	0.9×+0.4×	0.5×-0.8×
Leverage
Debt-to-equity	0.6×+0.4×	0.2×0.0×	0.2×0.0×	0.2×+0.1×
Debt-to-assets	0.3×+0.2×	0.1×0.0×	0.1×0.0×	0.1×+0.1×
Interest coverage	-36.9×+7.2×	-44.1×+44.7×	-88.8×-44.8×	-43.9×-15.1×
Per Share
Book value per share	$3.97-48.6%	$7.74-18.2%	$9.46-13.9%	$10.99-11.4%
Valuation
Market capitalization	$512.85M+13.1%	$1.25B-20.2%	$1.56B+33.0%	$1.18B-46.7%
Enterprise value	$598.35M+17.3%	$1.28B-19.0%	$1.58B+25.6%	$1.25B-38.4%
Price / sales	0.6×+0.1×	1.5×-0.6×	2.1×+0.3×	1.7×-1.5×
Price / book	1.5×+0.9×	1.8×-0.2×	2×+0.7×	1.3×-0.9×
EV / sales	0.7×+0.1×	1.5×-0.6×	2.1×+0.2×	1.8×-1.1×
Earnings yield	-78%-55.6pp	-10.2%+6.6pp	-16.8%-7.3pp	-9.5%-8.3pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Myriad Genetics.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Myriad Genetics's profit margins?: Myriad Genetics (MYGN) runs a 70.0% gross margin and a -46.9% operating margin, with a -48.2% net margin.
Where do Myriad Genetics's ratios come from?: Every ratio is computed from Myriad Genetics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.